WallStreetZenWallStreetZen

NASDAQ: RNA
Avidity Biosciences Inc Stock Forecast, Predictions & Price Target

Analyst price target for RNA

Based on 2 analysts offering 12 month price targets for Avidity Biosciences Inc.
Min Forecast
$35.00+129.36%
Avg Forecast
$42.50+178.51%
Max Forecast
$50.00+227.65%

Should I buy or sell RNA stock?

Based on 2 analysts offering ratings for Avidity Biosciences Inc.
Strong Buy
Strong Buy
1 analysts 50%
Buy
1 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their RNA stock forecasts and price targets.

RNA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-01-03
lockedlocked$00.00+00.00%2023-11-29

1 of 1

Forecast return on equity

Is RNA forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
35.49%

Forecast return on assets

Is RNA forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

RNA revenue forecast

What is RNA's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$2.7M-73.68%
Avg 2 year Forecast
$230.0M+2,169.34%
Avg 3 year Forecast
$685.6M+6,663.91%
RNA's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

RNA revenue growth forecast

How is RNA forecast to perform vs Biotechnology companies and vs the US market?
Company
299.76%
Industry
53.01%
Market
11.07%
RNA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
RNA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

RNA vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
RNA$15.26$42.50+178.51%Strong Buy
BLTE$45.80$58.67+28.09%Strong Buy
BCYC$25.98$46.86+80.36%Strong Buy
ZNTL$15.49$33.75+117.88%Strong Buy
TNGX$11.51$17.00+47.70%Strong Buy

Avidity Biosciences Stock Forecast FAQ

Is Avidity Biosciences Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: RNA) stock is to Strong Buy RNA stock.

Out of 2 analysts, 1 (50%) are recommending RNA as a Strong Buy, 1 (50%) are recommending RNA as a Buy, 0 (0%) are recommending RNA as a Hold, 0 (0%) are recommending RNA as a Sell, and 0 (0%) are recommending RNA as a Strong Sell.

If you're new to stock investing, here's how to buy Avidity Biosciences stock.

What is RNA's revenue growth forecast for 2024-2027?

(NASDAQ: RNA) Avidity Biosciences's forecast annual revenue growth rate of 299.76% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 53.01%, and it is also forecast to beat the US market's average forecast revenue growth rate of 11.07%.

Avidity Biosciences's revenue in 2024 is $10,136,000.On average, 1 Wall Street analysts forecast RNA's revenue for 2024 to be $197,702,146, with the lowest RNA revenue forecast at $197,702,146, and the highest RNA revenue forecast at $197,702,146. On average, 1 Wall Street analysts forecast RNA's revenue for 2026 to be $17,044,770,445, with the lowest RNA revenue forecast at $17,044,770,445, and the highest RNA revenue forecast at $17,044,770,445.

In 2027, RNA is forecast to generate $50,803,078,730 in revenue, with the lowest revenue forecast at $50,803,078,730 and the highest revenue forecast at $50,803,078,730.

What is RNA's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: RNA) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is RNA's Price Target?

According to 2 Wall Street analysts that have issued a 1 year RNA price target, the average RNA price target is $42.50, with the highest RNA stock price forecast at $50.00 and the lowest RNA stock price forecast at $35.00.

On average, Wall Street analysts predict that Avidity Biosciences's share price could reach $42.50 by Jan 3, 2025. The average Avidity Biosciences stock price prediction forecasts a potential upside of 178.51% from the current RNA share price of $15.26.

What is RNA's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: RNA) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.